Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Teismann

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegenerationPeter Teismann, Kim Tieu, Dong-Kug Choi, et al.
Neurobiology of Aging|January 10, 2012
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicityPeter Teismann, Kinnari Sathe, Angelika Bierhaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2003
Pathogenic role of glial cells in Parkinson's diseasePeter Teismann, Kim Tieu, Oren Cohen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson diseaseD C Wu, Vernice Jackson-Lewis, Miquel Vila, et al.
Annals of Neurology|July 6, 2004
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's diseaseKim Tieu, Celine Perier, Miquel Vila, et al.
The Journal of Clinical Investigation|September 17, 2003
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Celine Perier, Casper Caspersen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 2005
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in miceDong-Kug Choi, Subramaniam Pennathur, Celine Perier, et al.
Brain : a Journal of Neurology|July 26, 2013
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanismsCeline Perier, Andreas Bender, Elena García-Arumí, et al.
Brain : a Journal of Neurology|November 22, 2012
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathwayKinnari Sathe, Walter Maetzler, Johannes D Lang, et al.
Neurobiology of Disease|February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizinMatteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegenerationPeter Teismann, Kim Tieu, Dong-Kug Choi, et al.
Neurobiology of Aging|January 10, 2012
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicityPeter Teismann, Kinnari Sathe, Angelika Bierhaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2003
Pathogenic role of glial cells in Parkinson's diseasePeter Teismann, Kim Tieu, Oren Cohen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson diseaseD C Wu, Vernice Jackson-Lewis, Miquel Vila, et al.
Annals of Neurology|July 6, 2004
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's diseaseKim Tieu, Celine Perier, Miquel Vila, et al.
The Journal of Clinical Investigation|September 17, 2003
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Celine Perier, Casper Caspersen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 2005
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in miceDong-Kug Choi, Subramaniam Pennathur, Celine Perier, et al.
Brain : a Journal of Neurology|July 26, 2013
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanismsCeline Perier, Andreas Bender, Elena García-Arumí, et al.
Brain : a Journal of Neurology|November 22, 2012
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathwayKinnari Sathe, Walter Maetzler, Johannes D Lang, et al.
Neurobiology of Disease|February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizinMatteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Pageof 4